Clinical significance of the bacterium aerococcus urinae

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00023019

Enrollment

Registered

2020-09-22

Start date

2020-09-23

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

N39.0

Interventions

Group 1: Aerococcus evidence between 2010 and 2019 will be recorded and evaluated in terms of gender, age, underlying disease, location or type of infection and antibiogram Group 2: Patients with dete

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Detection of aerococcus urinae

Exclusion criteria

Exclusion criteria: not fit for consent

Design outcomes

Primary

Measure	Time frame
Examination of microbiological samples (throat, groin and stool) of 73 patients in which Aerococcus urinae (especially in the urine) has been detected, for the presence of Aerococcus urinae in these materials	—

Secondary

Measure	Time frame
clarification of prevalence and risk factors, find an entry gate	—

Countries

Germany

Contacts

Public ContactBastian Dirk

Medizinische Mikrobiologie UMG Göttingen

bastian.dirk@stud.uni-goettingen.de0160/94692811

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026